It took 323 days for the SARS vaccine to begin human trials in 2002, while the Ebola epidemic took 164 days and the H1N1 epidemic took only 89 days. However, with the Covid-19 pandemic, scientists achieved a miracle by shortening the time to 63 days, helping the vaccine quickly enter the human testing phase and achieve unexpected results. In particular, the Moderna vaccine—the “silver bullet” in the race against the epidemic—is expected to help the world return to normal soon.
Which country produces the Moderna vaccine?
Moderna Vaccine is a product invented by a leading biotechnology company in the US. Founded in 2010, Moderna is headquartered in Cambridge, Massachusetts (USA) and currently owns many copyrights related to RNA technology, including the COVID-19 vaccine.
The Moderna vaccine, also known as mRNA-1273, is the result of cooperation between Moderna and NIAID (US National Institute of Allergy and Infectious Diseases). A special feature of this vaccine is the application of RNA technology (messenger RNA – mRNA), which helps actively create antibodies.
The Moderna vaccine works by introducing into the human body the mRNA segment carrying genetic information of SARS-CoV-2. When injected, the body’s cells will produce virus surface proteins, helping the immune system train to create antibodies and prepare to fight pathogens.
The Moderna vaccine uses new RNA technology, quickly affecting the immune system. With advanced preparation processes and strict testing, the Moderna vaccine is proven to ensure effectiveness and safety for users.
Moderna Vaccine
Is Moderna Vaccine safe?
Moderna Vaccine has undergoes rigorous testing from the European Medicines Agency (EMA) and fully meets the criteria established by the Strategic Advisory Group of Experts on Immunization (SAGE) of the World Health Organization (WHO). This ensures that the vaccine meets safety and effectiveness standards in Covid-19 prevention.
After being approved by the EMA, the Moderna vaccine has been widely deployed in many countries in the European Union, as well as other countries such as the United States, Canada, Japan, Israel, etc. This demonstrates the level of trust and global acceptance of this vaccine.
Even though the vaccine has been proven safe, vaccinated people should be monitored for at least 15 minutes after vaccination to detect fishc unusual symptoms. In particular, people who have severe allergic reactions after the first dose should not continue to receive the next dose of vaccine to avoid adverse reactions.
In the long term, monitoring health after vaccination is very important. Medical professionals should continue to evaluate for possible side effects or adverse reactions. This helps ensure the safety and effectiveness of vaccines in the community.
Pfizer and BioNTech accuse Moderna of using invalid patent
Patent dispute between Pfizer, BioNTech and Moderna
Pharmaceutical company Pfizer (USA) and BioNTech (Germany) filed a lawsuit against Moderna at the London Court (UK) in September 2022 to request the revocation of two patents related to Moderna’s mRNA vaccine. This is part of the legal battle over intellectual property rights in the field of mRNA technology.
On April 23, 2023, the High Court in London began hearing a lawsuit between three large pharmaceutical companies. Pfizer and BioNTech accused Moderna of using invalid patents to prevent competition in the Covid-19 vaccine market. This patent dispute is attracting great attention due to its impact on the global pharmaceutical industry.
Previously, in August 2022, Moderna also sued Pfizer and BioNTech over the Comirnaty vaccine, demanding compensation for damages due to infringement of the company’s patent. Moderna claimed that its mRNA technology was illegally used by competitors to develop vaccines.
In 2022, Moderna achieved revenue of 6.7 billion USD from the Spikevax vaccine, while Pfizer earned 11.2 billion USD from the Comirnaty vaccine. These are the two leading mRNA vaccines on the market, playing an important role in the fight against the Covid-19 pandemic.
The trial process at the London Court is expected to last until mid-May 2023 before a final verdict is issued. Besides the lawsuit in the UK, these pharmaceutical companies are also facing patent disputes in Germany, the Netherlands, Belgium, the US and the European Patent Office.
This lawsuit not only affects the pharmaceutical industry but may also affect the development of mRNA technology in the future. The court’s decision will play an important role in determining intellectual property rights and fairness in the field of vaccines.
Side effects of Moderna vaccine
When receiving the Moderna vaccine, the injector may experience some common side effects. These reactions usually appear within 1 – 2 days after injection and can affect daily activities, but usually disappear on their own after a few days without causing serious harm.
Side effects at the injection site: Pain, swelling, redness at the injection area.
Body side effects
Chills, fatigue, headache, muscle and joint pain, nausea, vomiting vomiting.
Some cases may experience flu-like symptoms, but do not affect long-term health.
When receiving Moderna vaccine inn cold, fatigue, headache, muscle and joint pain, nausea, vomiting
What is the price of the Moderna vaccine?
Although the Moderna vaccine is highly effective in disease prevention, the price is still a concern for many people. In July 2020, a Moderna representative said the price of the Moderna vaccine ranges from 25.000 VND – 30 USD per dose of vaccine. This price mainly applies to the US and high-income countries. Compared to competitors in the market, Moderna has a significantly higher price.
Based on data on safety, effectiveness and quality, on June 29, 2021, the Ministry of Health conditionally approved the Moderna vaccine. to meet urgent needs in Covid-19 prevention and control in Vietnam. This is the 5th Covid-19 vaccine licensed in Vietnam, after AstraZeneca, Sputnik V, Pfizer and Sinopharm. In 2021, Vietnam is expected to receive about 5 million doses of Moderna vaccine, making an important contribution to the national vaccination campaign.